Načítá se...
P09.33 Feasibility and survival benefit of hypofractionated radiotherapy with concurrent temozolomide and bevacizumab in elderly patients with glioblastoma
BACKGROUND: Hypofractionated radiotherapy (HPRT) was often used for treatment of elderly patients with glioblastoma. This therapy was well tolerated, however, the prognosis was still dismal. Although dose escalation of HPRT (45Gy/15fr) might be effective, incidence of radiation injury could be incre...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464084/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.289 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|